Russia 's sovereign wealth fund says it will supply 100 million doses of its coronavirus vaccine Sputnik V to Indian pharmaceutical company Dr . Reddy ’s Laboratories Ltd . once it receives regulatory approval in India . 
The Russian Direct Investment Fund ( RDIF ) has agreed to cooperate with the Indian firm on clinical trials and distribution of the vaccine , it announced in a statement Wednesday . 
The announcement comes as India topped 5 million coronavirus cases Wednesday after reporting 90,123 new cases in the past 24 hours . 
Last week , CNN was the first to report a deal to supply India with millions of doses of its Sputnik vaccine was expected to be announced . 
" Upon regulatory approval in India , RDIF shall supply to Dr . Reddy ’s 100 million doses of the vaccine , " the RDIF statement said , adding that " subject to completion of successful trials and registration of the vaccine by regulatory authorities in India " deliveries could potentially begin in late 2020 . 
" India is amongst [ the ] most severely impacted countries from Covid 19 and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against Covid 19 , " RDIF CEO Kirill Dmitriev said in a press release . 
